Calip GS - Search Results

1

Characteristics Associated With Opioid and Antibiotic Prescribing by Dentists.

Hubbard CC, Evans CT, Calip GS, Rowan SA, Gellad WF, Campbell A, Gross AE, Hershow RC, McGregor JC, Sharp LK, Suda KJ. Hubbard CC, et al. Among authors: calip gs. Am J Prev Med. 2021 May;60(5):648-657. doi: 10.1016/j.amepre.2020.11.017. Epub 2021 Mar 19. Am J Prev Med. 2021. PMID: 33745816 Free PMC article.

2

Impact of the COVID-19 pandemic on treatment patterns for US patients with metastatic solid cancer.

Parikh RB, Takvorian SU, Vader D, Wileyto EP, Clark AS, Lee DJ, Goyal G, Rocque GB, Dotan E, Geynisman DM, Phull P, Spiess PE, Kim RY, Davidoff AJ, Gross CP, Neparidze N, Miksad RA, Calip GS, Hearn CM, Ferrell W, Shulman LN, Mamtani R, Hubbard RA; PRACTICE Investigators. Parikh RB, et al. Among authors: calip gs. medRxiv [Preprint]. 2021 Sep 23:2021.09.22.21263964. doi: 10.1101/2021.09.22.21263964. medRxiv. 2021. PMID: 34611665 Free PMC article. Updated. Preprint.

3

External validity of lymphoma clinical trials.

Calip GS, Royce TJ. Calip GS, et al. Blood. 2023 Aug 31;142(9):757-759. doi: 10.1182/blood.2023021222. Blood. 2023. PMID: 37651155 No abstract available.

4

End-of-Life Systemic Oncologic Treatment in the Immunotherapy Era: The Role of Race, Insurance, and Practice Setting.

Canavan M, Wang X, Ascha M, Miksad R, Showalter TN, Calip G, Gross CP, Adelson K. Canavan M, et al. J Clin Oncol. 2023 Oct 20;41(30):4729-4738. doi: 10.1200/JCO.22.02180. Epub 2023 Jun 20. J Clin Oncol. 2023. PMID: 37339389

5

Prognostic value of translocation 11;14 in patients with relapsed/refractory myeloma receiving anti-CD38 therapy.

Mohyuddin GR, Chakraborty R, Calip GS, Ascha MS, Wang X, Rubinstein SM, Tuchman S, Costa L, Haaland B, Giri S, Mian H, Fonseca R, Sborov D. Mohyuddin GR, et al. Among authors: calip gs. Blood Cancer J. 2022 Dec 16;12(12):168. doi: 10.1038/s41408-022-00769-4. Blood Cancer J. 2022. PMID: 36526617 Free PMC article. No abstract available.

6

Assessing the Contribution of Scanned Outside Documents to the Completeness of Real-World Data Abstraction.

Zhao Y, Howard R, Amorrortu RP, Stewart SC, Wang X, Calip GS, Rollison DE. Zhao Y, et al. Among authors: calip gs. JCO Clin Cancer Inform. 2023 Feb;7:e2200118. doi: 10.1200/CCI.22.00118. JCO Clin Cancer Inform. 2023. PMID: 36791386 Free article.

7

Evaluating External Validity of Oncology Biosimilar Safety Studies.

Calip GS, Altomare IP, Guadamuz JS. Calip GS, et al. JAMA Netw Open. 2023 Apr 3;6(4):e235776. doi: 10.1001/jamanetworkopen.2023.5776. JAMA Netw Open. 2023. PMID: 37022693 Free article. No abstract available.

8

Top-down Versus Step-up Prescribing Strategies for Tumor Necrosis Factor Alpha Inhibitors in Children and Young Adults with Inflammatory Bowel Disease.

Lee WJ, Briars L, Lee TA, Calip GS, Suda KJ, Schumock GT. Lee WJ, et al. Among authors: calip gs. Inflamm Bowel Dis. 2016 Oct;22(10):2410-7. doi: 10.1097/MIB.0000000000000880. Inflamm Bowel Dis. 2016. PMID: 27537053

9

Use of Tumor Necrosis Factor-Alpha Inhibitors in Children and Young Adults With Juvenile Idiopathic Arthritis or Rheumatoid Arthritis.

Lee WJ, Briars L, Lee TA, Calip GS, Suda KJ, Schumock GT. Lee WJ, et al. Among authors: calip gs. Pharmacotherapy. 2016 Dec;36(12):1201-1209. doi: 10.1002/phar.1856. Epub 2016 Dec 4. Pharmacotherapy. 2016. PMID: 27779782

10

Risk of serious bacterial infection associated with tumour necrosis factor-alpha inhibitors in children with juvenile idiopathic arthritis.

Lee WJ, Lee TA, Suda KJ, Calip GS, Briars L, Schumock GT. Lee WJ, et al. Among authors: calip gs. Rheumatology (Oxford). 2018 Feb 1;57(2):273-282. doi: 10.1093/rheumatology/kex049. Rheumatology (Oxford). 2018. PMID: 28431162

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

142 results

Search Page